Our recent study revealed that non-neuroendocrine small cell lung cancer (SCLC) is sensitive to the induction of ferroptosis due to upregulation of ether lipid synthesis. While neuroendocrine SCLC is ferroptosis resistant, it acquires addiction to the thioredoxin pathway. Combined redox pathway targeting therefore achieves efficient anti-tumor activity in heterogenous SCLC.
Keywords: Ferroptosis; GPX4; GSH; PUFA; SCLC; cell death; ether lipids; lipid peroxidation; neuroendocrine cancer; thioredoxin.
© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.